TAFAZZIN and Barth syndrome: In the current work, we characterized a new mouse model of BTHS, examining the phenotype of the Taz-KO mouse model at three ages corresponding to the human periods of young adulthood (i.e., 3 months), early middle-age (i.e., 6 months) and late middle-age (i.e., 12 months) [34].